↓ Skip to main content

cGMP: Generators, Effectors and Therapeutic Implications

Overview of attention for book
Cover of 'cGMP: Generators, Effectors and Therapeutic Implications'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 A Short History of cGMP, Guanylyl Cyclases, and cGMP-Dependent Protein Kinases
  3. Altmetric Badge
    Chapter 2 Biochemistry of soluble guanylate cyclase.
  4. Altmetric Badge
    Chapter 3 Genetic Mouse Models of the NO Receptor ‘Soluble’ Guanylyl Cyclases
  5. Altmetric Badge
    Chapter 4 Function and Dysfunction of Mammalian Membrane Guanylyl Cyclase Receptors: Lessons from Genetic Mouse Models and Implications for Human Diseases
  6. Altmetric Badge
    Chapter 5 Phosphodiesterases in the Central Nervous System
  7. Altmetric Badge
    Chapter 6 Structural and biochemical aspects of tandem GAF domains.
  8. Altmetric Badge
    Chapter 7 Cyclic Nucleotide-Gated Channels
  9. Altmetric Badge
    Chapter 8 cGMP Regulated Protein Kinases (cGK)
  10. Altmetric Badge
    Chapter 9 cGK Substrates
  11. Altmetric Badge
    Chapter 10 Biochemical Detection of cGMP From Past to Present: An Overview
  12. Altmetric Badge
    Chapter 11 Novel Techniques for Real-Time Monitoring of cGMP in Living Cells
  13. Altmetric Badge
    Chapter 12 NO and sGC-Stimulating NO Donors
  14. Altmetric Badge
    Chapter 13 NO-independent, haem-dependent soluble guanylate cyclase stimulators.
  15. Altmetric Badge
    Chapter 14 NO- and Haem-Independent Soluble Guanylate Cyclase Activators
  16. Altmetric Badge
    Chapter 15 Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.
  17. Altmetric Badge
    Chapter 16 Cyclic GMP-Hydrolyzing Phosphodiesterases
  18. Altmetric Badge
    Chapter 17 cGMP-Dependent Protein Kinase Modulators
  19. Altmetric Badge
    Chapter 18 cGMP-Dependent Protein Kinase as a Modifier of Behaviour
  20. Altmetric Badge
    Chapter 19 cGMP in the Vasculature
  21. Altmetric Badge
    Chapter 20 Modulating cGMP to Treat Lung Diseases
  22. Altmetric Badge
    Chapter 21 Modulation of cGMP in heart failure: a new therapeutic paradigm.
  23. Altmetric Badge
    Chapter 22 Erectile Dysfunction and Lower Urinary Tract
  24. Altmetric Badge
    Chapter 23 cGMP and cGMP-Dependent Protein Kinase in Platelets and Blood Cells
  25. Altmetric Badge
    Chapter 24 cGMP Signalling in the Mammalian Brain: Role in Synaptic Plasticity and Behaviour
Attention for Chapter 15: Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

blogs
1 blog
patent
3 patents
wikipedia
12 Wikipedia pages

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
433 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.
Chapter number 15
Book title
cGMP: Generators, Effectors and Therapeutic Implications
Published in
Handbook of experimental pharmacology, January 2009
DOI 10.1007/978-3-540-68964-5_15
Pubmed ID
Book ISBNs
978-3-54-068960-7, 978-3-54-068964-5
Authors

Lincoln R. Potter, Andrea R. Yoder, Darcy R. Flora, Laura K. Antos, Deborah M. Dickey, Potter, Lincoln R., Yoder, Andrea R., Flora, Darcy R., Antos, Laura K., Dickey, Deborah M.

Abstract

Natriuretic peptides are a family of three structurally related hormone/ paracrine factors. Atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) are secreted from the cardiac atria and ventricles, respectively. ANP signals in an endocrine and paracrine manner to decrease blood pressure and cardiac hypertrophy. BNP acts locally to reduce ventricular fibrosis. C-type natriuretic peptide (CNP) primarily stimulates long bone growth but likely serves unappreciated functions as well. ANP and BNP activate the transmembrane guanylyl cyclase, natriuretic peptide receptor-A (NPR-A). CNP activates a related cyclase, natriuretic peptide receptor-B (NPR-B). Both receptors catalyze the synthesis of cGMP, which mediates most known effects of natriuretic peptides. A third natriuretic peptide receptor, natriuretic peptide receptor-C (NPR-C), clears natriuretic peptides from the circulation through receptor-mediated internalization and degradation. However, a signaling function for the receptor has been suggested as well. Targeted disruptions of the genes encoding all natriuretic peptides and their receptors have been generated in mice, which display unique physiologies. A few mutations in these proteins have been reported in humans. Synthetic analogs of ANP (anaritide and carperitide) and BNP (nesiritide) have been investigated as potential therapies for the treatment of decompensated heart failure and other diseases. Anaritide and nesiritide are approved for use in acute decompensated heart failure, but recent studies have cast doubt on their safety and effectiveness. New clinical trials are examining the effect of nesiritide and novel peptides, like CD-NP, on these critical parameters. In this review, the history, structure, function, and clinical applications of natriuretic peptides and their receptors are discussed.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 433 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 2 <1%
Denmark 2 <1%
Germany 1 <1%
South Africa 1 <1%
United States 1 <1%
Unknown 426 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 65 15%
Researcher 47 11%
Student > Master 46 11%
Student > Ph. D. Student 45 10%
Student > Doctoral Student 30 7%
Other 57 13%
Unknown 143 33%
Readers by discipline Count As %
Medicine and Dentistry 91 21%
Biochemistry, Genetics and Molecular Biology 57 13%
Agricultural and Biological Sciences 53 12%
Pharmacology, Toxicology and Pharmaceutical Science 19 4%
Engineering 11 3%
Other 54 12%
Unknown 148 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 April 2023.
All research outputs
#2,121,342
of 25,837,817 outputs
Outputs from Handbook of experimental pharmacology
#72
of 701 outputs
Outputs of similar age
#9,006
of 187,494 outputs
Outputs of similar age from Handbook of experimental pharmacology
#4
of 32 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 701 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.2. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,494 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.